Moderna Seeks to Dismiss Covid-19 Vaccine Patent Lawsuit

Österreich Nachrichten Nachrichten

Moderna Seeks to Dismiss Covid-19 Vaccine Patent Lawsuit
Österreich Neuesten Nachrichten,Österreich Schlagzeilen
  • 📰 WSJhealth
  • ⏱ Reading Time:
  • 24 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 53%

Vaccine-maker Moderna is trying to fend off legal claims of patent infringement, arguing that federal patent law protects it

Moderna says its Covid-19 vaccine doesn’t infringe the patents of two small biotech rivals.Updated May 6, 2022 9:17 pm ET

Moderna Inc. is trying to fend off rival companies’ claims that its Covid-19 vaccine infringes their patents, arguing that the companies may only pursue their claims seeking royalties from the federal government. Moderna on Friday filed a motion to dismiss some of the patent-infringement claims in the lawsuit, which was filed in February by two small biotechnology companies, Arbutus Biopharma Corp. and Genevant Sciences GmbH, in federal court in Delaware.

Wir haben diese Nachrichten zusammengefasst, damit Sie sie schnell lesen können. Wenn Sie sich für die Nachrichten interessieren, können Sie den vollständigen Text hier lesen. Weiterlesen:

WSJhealth /  🏆 413. in US

Österreich Neuesten Nachrichten, Österreich Schlagzeilen

Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.

Candlelit Vigil Will Press Biden to Deliver Covid-19 Vaccine Patent WaiverCandlelit Vigil Will Press Biden to Deliver Covid-19 Vaccine Patent Waiver'Advocates across the globe are calling for the WTO to urgently deliver a waiver that can help ensure that all countries are equipped with the tools needed to save lives and bring the pandemic under control,' says Public_Citizen. TRIPSwaiver
Weiterlesen »

FDA restricts use of Johnson & Johnson COVID vaccine due to blood clot riskFDA restricts use of Johnson & Johnson COVID vaccine due to blood clot riskThe Food and Drug Administration put rigid limits on who can receive Johnson & Johnson’s one-dose COVID-19 vaccine on Thursday, saying the vaccine should only be given to people who cannot receive a different vaccine or those who specifically request it.
Weiterlesen »

FDA restricts Johnson & Johnson's COVID-19 vaccine due to rare but serious risk of blood clotsFDA restricts Johnson & Johnson's COVID-19 vaccine due to rare but serious risk of blood clotsU.S. regulators on Thursday strictly limited who can receive Johnson & Johnson's COVID-19 vaccine due to the ongoing risk of rare but serious blood clots.
Weiterlesen »

FDA restricts J&J’s COVID-19 vaccine due to blood clot riskFDA restricts J&J’s COVID-19 vaccine due to blood clot riskU.S. regulators are strictly limiting who can receive Johnson & Johnson’s COVID-19 vaccine due to a rare but serious risk of blood clots.
Weiterlesen »

Johnson & Johnson Covid-19 Vaccine Use Limited By US Food And Drug Administration AdvisoryJohnson & Johnson Covid-19 Vaccine Use Limited By US Food And Drug Administration AdvisoryThe claims that Covid-19 vaccine are “safe and effective” now comes with a “But.” The US Food and Drug Administration announced Thursday that the Johnson & Johnson/Janss…
Weiterlesen »

FDA restricts Johnson & Johnson's COVID-19 vaccine due to blood clot riskFDA restricts Johnson & Johnson's COVID-19 vaccine due to blood clot riskU.S. regulators are strictly limiting who can receive Johnson & Johnson’s COVID-19 vaccine due to a rare but serious risk of blood clots.
Weiterlesen »



Render Time: 2025-03-21 23:33:53